Stock CTKB CYTEK BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
5.81 USD +0.17% Intraday chart for Cytek Biosciences, Inc. -2.68% -36.29%
Mar. 20 Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing MT
Mar. 19 Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing
MT
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance
MT
Cytek® Biosciences Names William McCombe Chief Financial Officer
GL
Cytek® Biosciences Names William McCombe Chief Financial Officer
AQ
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics
CI
Cytek Biosciences, Inc. Announces CFO Changes
CI
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China
MT
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
GL
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
AQ
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China
CI
Piper Sandler Trims Price Target on Cytek Biosciences to $10 From $11, Maintains Overweight Rating
MT
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on May 19, 2023.
CI
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024
CI
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
GL
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Cytek Biosciences, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Cytek Biosciences to Participate in Upcoming Investor Conferences
GL
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
GL
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University
MT
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTKB Stock
  4. News Cytek Biosciences, Inc.